Large-scale identification of spliced peptides using our discovery workflow will offer the possibility of enhancing the breadth of vaccine-induced CD8+ T cell responses not only in HIV-1 infection but also in other infectious diseases, cancers, and autoimmune disorders. Here, CD8A is linked to cancer.